- Home
- GRCE vs NYC Comparison
GRCE vs NYC Comparison
Compare GRCE & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRCE
- NYC
- Stock Information
- Founded
- GRCE 2002
- NYC 2013
- Country
- GRCE United States
- NYC United States
- Employees
- GRCE N/A
- NYC N/A
- Industry
- GRCE
- NYC Real Estate
- Sector
- GRCE
- NYC Finance
- Exchange
- GRCE NYSE
- NYC Nasdaq
- Market Cap
- GRCE 42.4M
- NYC 40.9M
- IPO Year
- GRCE N/A
- NYC N/A
- Fundamental
- Price
- GRCE $3.08
- NYC $13.55
- Analyst Decision
- GRCE Strong Buy
- NYC
- Analyst Count
- GRCE 1
- NYC 0
- Target Price
- GRCE $12.00
- NYC N/A
- AVG Volume (30 Days)
- GRCE 62.2K
- NYC 4.2K
- Earning Date
- GRCE 08-15-2025
- NYC 08-08-2025
- Dividend Yield
- GRCE N/A
- NYC N/A
- EPS Growth
- GRCE N/A
- NYC N/A
- EPS
- GRCE N/A
- NYC N/A
- Revenue
- GRCE N/A
- NYC $58,397,000.00
- Revenue This Year
- GRCE N/A
- NYC $8.40
- Revenue Next Year
- GRCE N/A
- NYC $1.62
- P/E Ratio
- GRCE N/A
- NYC N/A
- Revenue Growth
- GRCE N/A
- NYC N/A
- 52 Week Low
- GRCE $1.75
- NYC $7.89
- 52 Week High
- GRCE $4.97
- NYC $16.30
- Technical
- Relative Strength Index (RSI)
- GRCE N/A
- NYC 51.18
- Support Level
- GRCE N/A
- NYC $13.63
- Resistance Level
- GRCE N/A
- NYC $14.73
- Average True Range (ATR)
- GRCE 0.00
- NYC 0.78
- MACD
- GRCE 0.00
- NYC -0.27
- Stochastic Oscillator
- GRCE 0.00
- NYC 22.08
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage. Other products are GTx-102 Ataxia-Telangiectasia, GTx-101 Postherpetic Neuralgia, and GTx-201.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.